Author:
Jenkins D J A,Kendall C W C,Nguyen T H,Teitel J,Marchie A,Chiu M,Taha A Y,Faulkner D A,Kemp T,Wong J M W,de Souza R,Emam A,Trautwein E A,Lapsley K G,Holmes C,Josse R G,Leiter L A,Singer W
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Medicine (miscellaneous)
Reference54 articles.
1. Abu-Zeid HA, Chapman JM (1976). The relation between hemoglobin level and the risk for ischemic heart disease: a prospective study. J Chronic Dis 29, 395–403.
2. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002). The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 288, 2998–3007.
3. Arant CB, Wessel TR, Olson MB, Bairey Merz CN, Sopko G, Rogers WJ et al. (2004). Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol 43, 2009–2014.
4. Barbieri M, Ragno E, Benvenuti E, Zito GA, Corsi A, Ferrucci L et al. (2001). New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia 44, 1232–1237.
5. Corti MC, Gaziano M, Hennekens CH (1997). Iron status and risk of cardiovascular disease. Ann Epidemiol 7, 62–68.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献